Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Salute | Prodotti farmaceutici | 7,48 Mrd € | 45,3x | 8,94 € | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,9% Rialzo | Fai l’upgrade a Pro+ | ||
Grifols | Madrid | Salute | Prodotti farmaceutici | 7,48 Mrd € | 45,3x | 10,90 € | -2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 48,3% Rialzo | Fai l’upgrade a Pro+ | ||
Laborat.Rovi | Madrid | Salute | Prodotti farmaceutici | 3,19 Mrd € | 20,2x | 62,20 € | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Almirall | Madrid | Salute | Prodotti farmaceutici | 1,81 Mrd € | -40,1x | 8,40 € | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,4% Rialzo | Fai l’upgrade a Pro+ | ||
Pharma Mar | Madrid | Salute | Prodotti farmaceutici | 1,29 Mrd € | 2.100x | 73,50 € | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14% Rialzo | Fai l’upgrade a Pro+ | ||
Faes Farma | Madrid | Salute | Prodotti farmaceutici | 1,08 Mrd € | 11,1x | 3,47 € | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,1% Rialzo | Fai l’upgrade a Pro+ | ||
Natac Natural Ingredients | Madrid | Salute | Prodotti farmaceutici | 269,58 Mln € | -39,2x | 0,62 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Laboratorio Reig Jofre | Madrid | Salute | Prodotti farmaceutici | 227,37 Mln € | 23,9x | 2,84 € | -2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 41,4% Rialzo | Fai l’upgrade a Pro+ | ||
Labiana Health | Madrid | Salute | Prodotti farmaceutici | 15,07 Mln € | -11,7x | -0,15 | 2,18 € | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,1% Rialzo | Fai l’upgrade a Pro+ |